PathologybioRxivPreprint
Moderate-term dimethyl fumarate treatment reduces pathology of dystrophic skeletal and cardiac muscle in a mouse model
Stephanie Kourakis, Cara A. Timpani, Ryan M. Bagaric…·Emma Rybalka
This study shows that moderate-term dimethyl fumarate treatment reduces dystrophic muscle pathology in a mouse model of Duchenne muscular dystrophy, with anti-inflammatory, anti-fibrotic, and anti-lipogenic effects.
2 citations